Completed OBSERVATIONAL NCT02730468

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

Sponsor: Karius, Inc.

Conditions Sepsis

Updated 11 times since 2017 Last updated: Oct 26, 2017 Started: Apr 30, 2016 Primary completion: Sep 30, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Sepsis and is currently completed. Karius, Inc. leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Nov 2017 — Apr 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Aug 2017 — Nov 2017 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karius, Inc.
Stanford University

Data source: Karius, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States